$20.29 $0.20 per serving
Product analysis
Ginkgo Biloba Extract 120 mg offers a focused ginkgo supplement with a possible, limited connection to attention and memory tasks. Incomplete extract details make it harder to compare with the specific preparations behind those findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
The ginkgo compound types are named, but that does not establish a particular extract's quality. Calcium's form is also unstated, limiting comparison of that ingredient.
Ingredient Transparency65
Both ingredient amounts are disclosed. The calcium form and ginkgo composition are incomplete, leaving uncertainty about the exact preparation.
Value For Money40
A clear value advantage cannot be established for ginkgo or calcium. The available cost information does not support a confident comparison with alternatives.
Customer Satisfaction89
Customers give very positive feedback across thousands of ratings. That is a substantial satisfaction history, though it does not establish improvements in memory or attention.
Product Focus58
Ginkgo is the main ingredient linked to attention and related brain-health interests. The findings are mixed, so dependable memory or productivity improvements should not be expected.
- Format
Capsule - Container
- 100 Veggie DRcap(s)
- Per serving
- $0.20
- Customer rating
- 4.8 · 2,904 ratings
Goals
Impact
Moderate effect
Ginkgo at 120 mg has mixed cognitive findings, with no benefit on memory, attention or concentration in the supplied healthy-older-adult trial. Its presence offers limited support for a reliable improvement in everyday productivity.
How this product is rated for Productivity Boost
Ingredient fit80
The saved assessment identifies goal-related ingredients, although their practical relevance depends on the evidence and preparation. The saved amount assessment is relatively strong across the ingredients it counts.
Goal fit
The saved assessment identifies goal-related ingredients, although their practical relevance depends on the evidence and preparation.
Dose adequacy
The saved amount assessment is relatively strong across the ingredients it counts.
Pathways13
The strongest saved contribution is to the brain-function pathway, with limited overall coverage. None of the listed pathways reaches the saved coverage threshold.
Depth
The strongest saved contribution is to the brain-function pathway, with limited overall coverage.
Breadth
None of the listed pathways reaches the saved coverage threshold.
Evidence53
Ginkgo provides the strongest evidence contribution among the ingredients counted at qualifying amounts. Preparation matching is complete for the qualifying ingredients.
Evidence strength
Ginkgo provides the strongest evidence contribution among the ingredients counted at qualifying amounts.
Studied preparation
The qualifying ingredients have a saved match to the preparation criteria.
Formulation logic100
The saved assessment finds the required ingredient relationships satisfied and no configured conflicts; all counted ingredients meet its minimum amount criterion.
Partner coverage
The counted ingredients can contribute alone or have their required partner present.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients meet the saved minimum amount criterion; that criterion is not a promise of benefit.
Impact
Moderate effect
Ginkgo extract at 120 mg has a limited connection to attention speed and brain blood flow. Its standardization markers do not identify the particular studied extract, and the supplied findings do not support assuming long-term memory improvement.
How this product is rated for Cognitive Support
Ingredient fit80
Relevant ingredients sit within a broader formula with several other purposes, limiting its focus on cognitive support. The assessed amount reaches the saved reference level.
Goal fit
Relevant ingredients sit within a broader formula with several other purposes, limiting its focus on cognitive support.
Dose adequacy
The assessed amount reaches the saved reference level.
Pathways40
The strongest saved connection is cerebral blood flow, with moderate coverage. One cognitive pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.
Depth
The strongest saved connection is cerebral blood flow, with moderate coverage.
Breadth
One cognitive pathway reaches the saved coverage threshold; the wider range of pathways remains uncovered.
Evidence25
Ginkgo supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters. The assessed preparation is not identified as a studied preparation.
Evidence strength
Ginkgo supplies the strongest saved evidence finding at the assessed amount; the scope of its actual cognitive evidence still matters.
Studied preparation
The assessed preparation is not identified as a studied preparation.
Formulation logic100
The assessed ingredients can work alone or have their required partner. No configured ingredient conflict was found in the supplied assessment. All assessed ingredients reach the saved minimum amount threshold.
Partner coverage
The assessed ingredients can work alone or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
All assessed ingredients reach the saved minimum amount threshold.
Impact
Moderate effect
Ginkgo at 120 mg is the main relevant ingredient, with a limited, situation-dependent relationship to cognitive performance. The supplied assessment centers on brain energy processes and retains mixed evidence for general adult benefit.
How this product is rated for Brain Health
Ingredient fit80
The relevant ingredients fit the goal, with the declared amounts and broader formula focus shaping their contribution.
Goal fit
A relevant brain-health ingredient is present, alongside a broader nutritional focus.
Dose adequacy
The assessed ingredient amount reaches the supplied comparison range.
Pathways43
The main assessed contribution is concentrated in brain energy processes.
Depth
The strongest saved finding concerns brain energy processes, with meaningful but limited coverage.
Breadth
The saved findings concentrate on brain energy processes, rather than several well-covered processes.
Evidence58
Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution. The saved assessment recognizes the preparation for the ingredients included in this finding.
Evidence strength
Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution.
Studied preparation
The saved assessment recognizes the preparation for the ingredients included in this finding.
Formulation logic100
The assessed ingredients need no additional partner, and no configured conflicts were found.
Partner coverage
The assessed ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
The ingredients included in this saved finding meet its amount threshold.
Impact
Moderate effect
The 120 mg ginkgo serving has a possible connection to selected attention and memory tasks. Findings are mixed, and small acute results do not establish reliable concentration improvement or a sustained benefit.
How this product is rated for Mental Focus
Ingredient fit80
Relevant ingredients form a substantial part of the assessed formula, alongside other nutritional or health uses. The assessed amounts reach the full saved exposure comparisons; this does not guarantee an effect.
Goal fit
Relevant ingredients form a substantial part of the assessed formula, alongside other nutritional or health uses.
Dose adequacy
The assessed amounts reach the full saved exposure comparisons; this does not guarantee an effect.
Pathways44
The strongest assessed connection is cerebral energy supply, with moderate coverage. One assessed mechanism reaches the saved coverage threshold, so coverage is narrow.
Depth
The strongest assessed connection is cerebral energy supply, with moderate coverage.
Breadth
One assessed mechanism reaches the saved coverage threshold, so coverage is narrow.
Evidence62
Ginkgo supplies the strongest evidence connection at the assessed amounts. The comparison does not imply improved focus in every user. The ingredients included in the saved effective-amount comparison meet its preparation criteria; that alone does not prove a general focus benefit.
Evidence strength
Ginkgo supplies the strongest evidence connection at the assessed amounts. The comparison does not imply improved focus in every user.
Studied preparation
The ingredients included in the saved effective-amount comparison meet its preparation criteria; that alone does not prove a general focus benefit.
Formulation logic100
The assessed ingredients can stand alone or have the required partner present. No configured ingredient conflicts were identified. 1 of 1 meet the saved minimum exposure comparison. Meeting it does not guarantee an effect.
Partner coverage
The assessed ingredients can stand alone or have the required partner present.
Conflicts
No configured ingredient conflicts were identified.
Effective doses
1 of 1 meet the saved minimum exposure comparison. Meeting it does not guarantee an effect.
Impact
Moderate effect
Whether ginkgo helps everyday vision is unclear. Its eye-related use concerns specific extracts and people with normal-tension glaucoma, with inconsistent outcomes. A generic ginkgo preparation cannot be assumed to have the same effects, and the amount alone does not tell you whether it will improve visual function.
How this product is rated for Eye Health
Ingredient fit60
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Goal fit
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Dose adequacy
Ginkgo : 120 mg. These serving amounts do not guarantee better vision.
Pathways40
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Depth
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Breadth
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Evidence64
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Evidence strength
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Studied preparation
The declared nutrient forms do not by themselves show that the complete eye-health combination is reproduced.
Formulation logic100
No particular ingredient conflict is identified.
Partner coverage
No missing required ingredient partner is identified.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Ginkgo : 120 mg. These serving amounts do not guarantee better vision.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calcium | 36 mg | |
Ginkgo biloba Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones) | 120 mg |
A serving lists 120 mg of ginkgo leaf extract. The recorded marker percentages are 24% flavones and 6% terpenes, describing the extract’s composition.
How this ingredient is rated
Composition and Label Disclosure70
The extract is listed as 24% flavones and 6% terpenes. No ginkgolic acid limit is recorded in the saved facts.
Marker and Preparation Disclosure
The extract is listed as 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
No ginkgolic acid limit is recorded in the saved facts.
Composition and Label Disclosure100
A serving lists 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
A serving lists 120 mg of ginkgo leaf extract.
Commercial Price and Usability
No price comparison was evaluated.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].